Skip to content

A prospective, randomized, open-label, active-controlled, real-world study of Tianmeng Oral Liquid in the treatment of insomnia

A prospective, randomized, open-label, active-controlled, real-world study of Tianmeng Oral Liquid in the treatment of insomnia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000582
Enrollment
Unknown
Registered
2026-03-18
Start date
2024-10-31
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Research Group:Tianmeng Oral Liquid
Control Group:Wuling Capsule

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–75 years, with no gender restriction. 2.Clinically diagnosed with insomnia. 3.Traditional Chinese Medicine (TCM) syndrome differentiation: deficiency of both heart and spleen, disharmony between heart and kidney, or deficiency of heart-gallbladder qi. 4.Receiving treatment with Tianmeng Oral Liquid or Wuling Capsule. 5.Voluntarily agree to participate in this clinical study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to Tianmeng Oral Liquid or other study medications. 2.Pregnant or lactating women, or women with pregnancy plans. 3.Patients who are currently taking regular medications for insomnia, depression, anxiety, or other central nervous system–acting drugs, or receiving psychological or physical therapy, and cannot discontinue such treatments during the study period. 4.Patients considered ineligible for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Change in PQSI score;

Secondary

MeasureTime frame
Change in PQSI score;Clinical response rate;Change in ISI score;Change in individual factor scores of PQSI;Change in sleep diary parameters;Change in TCM syndrome score;Comparison of dosage of rescue medication;Proportion of subjects taking rescue medication;

Countries

China

Contacts

Public ContactWang Jia

Zhejiang Provincial Hospital of Traditional Chinese Medicine

jia_wang@126.com13605716556

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026